74 related articles for article (PubMed ID: 10406683)
1. Metallic surface modification.
De Scheerder I; Verbeken E; Van Humbeeck J
Semin Interv Cardiol; 1998; 3(3-4):139-44. PubMed ID: 10406683
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM
Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526
[TBL] [Abstract][Full Text] [Related]
3. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
4. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
5. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
[TBL] [Abstract][Full Text] [Related]
6. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
7. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
[TBL] [Abstract][Full Text] [Related]
9. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents.
De Scheerder I; Wang K; Wilczek K; Meuleman D; Van Amsterdam R; Vogel G; Piessens J; Van de Werf F
Circulation; 1997 Mar; 95(6):1549-53. PubMed ID: 9118524
[TBL] [Abstract][Full Text] [Related]
10. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
11. Experimental Evaluation of a New Single Wire Tantalum Coil Coronary Stent (Wiktor-iª).
Wang K; Verbeken E; Zhou XR; De Scheerder IK
J Invasive Cardiol; 1998 Mar; 10(2):64-69. PubMed ID: 10762768
[TBL] [Abstract][Full Text] [Related]
12. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
[TBL] [Abstract][Full Text] [Related]
13. Low-energy gamma-emitting stents inhibit intimal hyperplasia with minimal "edge effects" in a pig coronary artery model.
Kutryk MJ; Kuliszewski MA; Jaffe R; Tio FO; Janicki C; Sweet WL; Sparkes JD; Strauss BH
Cardiovasc Revasc Med; 2007; 8(1):28-37. PubMed ID: 17293266
[TBL] [Abstract][Full Text] [Related]
14. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
15. Comparative pathology: radiation-induced coronary artery disease in man and animals.
Virmani R; Farb A; Carter AJ; Jones RM
Semin Interv Cardiol; 1998; 3(3-4):163-72. PubMed ID: 10406688
[TBL] [Abstract][Full Text] [Related]
16. Experimental efficacy of an everolimus eluting cobalt chromium stent.
Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
[TBL] [Abstract][Full Text] [Related]
17. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
[TBL] [Abstract][Full Text] [Related]
18. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
Koutouzis M; Papalois A; Kyrzopoulos S; Dafnomili P; Kyriakides ZS
Cardiol J; 2008; 15(5):458-62. PubMed ID: 18810722
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
Huang Y; Salu K; Liu X; Li S; Wang L; Verbeken E; Bosmans J; De Scheerder I
Heart; 2004 Feb; 90(2):195-9. PubMed ID: 14729797
[TBL] [Abstract][Full Text] [Related]
20. Estrogen decreases neointimal hyperplasia and improves re-endothelialization in pigs.
Kyriakides ZS; Lymberopoulos E; Papalois A; Kyrzopoulos S; Dafnomili V; Sbarouni E; Kremastinos DT
Int J Cardiol; 2006 Oct; 113(1):48-53. PubMed ID: 16356566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
